Article Information
History
- July 23, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- MAJ Sujan1,2,
- HS Skarstad1,
- G Rosvold1,
- SL Fougner3,4,
- SA Nyrnes1,5,
- AC Iversen3,6,
- T Follestad3,7,
- KÅ Salvesen2,3 and
- T Moholdt1,2,*
- 1Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway
- 2Department of Women’s Health, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway
- 3Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway
- 4Department of Endocrinology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway
- 5Children’s clinic, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway
- 6Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim, Norway
- 7Clinical Research Unit Central Norway, St. Olavs Hospital, Trondheim Norway
- ↵*Corresponding author Postal address: NTNU, Faculty of Medicine and Health Sciences, Department of Circulation and Medical Imaging, Postbox 8905, 7491 Trondheim, Norway trine.moholdt{at}ntnu.no
Posted July 23, 2023.
A randomised controlled trial of preconception lifestyle intervention on maternal and offspring health in people with increased risk of gestational diabetes: study protocol for the BEFORE THE BEGINNING trial
